Status:

UNKNOWN

National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension

Lead Sponsor:

University of Cambridge

Collaborating Sponsors:

British Heart Foundation

Medical Research Council

Conditions:

Pulmonary Arterial Hypertension

Eligibility:

All Genders

Brief Summary

Pulmonary arterial hypertension (PAH), or high blood pressure in the lungs, is a rare condition that can shorten life. Although the cause of this disease is usually unknown, in about 70% of heritable ...

Detailed Description

What does the study involve? PAH patients will be seen at their local centre by their service team but they will have additional bloods taken. Relatives of PAH patients will be seen every year at the...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Inclusion Criteria-Patient
  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, any age
  • Diagnosed with idiopathic, anorexigen-induced,heritable PAH, PVOD/PCH. Inclusion Criteria-Relative
  • Participant is willing and able to give informed consent for participation in the study.
  • Male or Female, any age
  • Has a family member diagnosed with idiopathic, anorexigen-induced, PVOD/PCH or heritable PAH
  • Exclusion Criteria-Patient
  • The participant may not enter the study if ANY of the following apply:
  • Patient is unable to give informed consent.
  • Not suffering from idiopathic, anorexigen-induced, PVOD/PCH or heritable PAH
  • Exclusion Criteria-Relative
  • The participant may not enter the study if ANY of the following apply:
  • • Patient is unable to give informed consent.
  • Inclusion criteria-Controls
  • Participant is willing and able to give informed consent for participation in the study.
  • Self-reported to be healthy
  • Age range up to 75 years

Exclusion

    Key Trial Info

    Start Date :

    February 1 2014

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2022

    Estimated Enrollment :

    3600 Patients enrolled

    Trial Details

    Trial ID

    NCT01907295

    Start Date

    February 1 2014

    End Date

    December 1 2022

    Last Update

    May 20 2022

    Active Locations (8)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (8 locations)

    1

    Royal United Hospitals Bath

    Bath, United Kingdom, BA1 3NG

    2

    Royal Papworth Hospital NHS Trust

    Cambridge, United Kingdom

    3

    Golden Jubilee National Hospital

    Glasgow, United Kingdom

    4

    Imperial Hospital

    London, United Kingdom